MacroGenics
MGNX
#9393
Rank
ยฃ65.05 M
Marketcap
ยฃ1.03
Share price
-0.72%
Change (1 day)
-61.29%
Change (1 year)

Earnings for MacroGenics (MGNX)

Earnings in 2025 (TTM): -ยฃ57.11 Million

According to MacroGenics's latest financial reports the company's current earnings are ยฃ0.12 Billion. In 2024 the company made an earning of -ยฃ49.56 Million a decrease over its 2023 earnings that were of -ยฃ6.8 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for MacroGenics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.11 Million15.23%
2024 -ยฃ49.56 Million628.88%
2023 -ยฃ6.8 Million-92.44%
2022 -ยฃ89.9 Million-40.75%
2021 -ยฃ0.16 Billion55.79%
2020 -ยฃ97.39 Million-14.54%
2019 -ยฃ0.12 Billion-11.46%
2018 -ยฃ0.13 Billion773.65%
2017 -ยฃ14.74 Million-66.47%
2016 -ยฃ43.94 Million190.61%
2015 -ยฃ15.12 Million-47.43%
2014 -ยฃ28.76 Million14585.78%
2013 -ยฃ0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-ยฃ0.11 Billion 84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.89 B-15,937.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.33 B-30,953.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.42 B-13,310.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.18 B-11,115.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.89 B-30,170.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B-10,834.00%๐Ÿ‡บ๐Ÿ‡ธ USA